Teva collaboration agreement aims to accelerate clinical data generation for TEV-56278 and develop Anti-PD1-IL2 Therapy.

Anne Wojcicki, co-founder and former CEO of 23andMe, is set to regain control of the DNA-testing company after a nonprofit ...

Ecolab has launched a new resin designed to help achieve cost savings and optimize operations throughout the antibody ...

The collaboration aims to advance the discovery and development of novel oral candidates.

Merck also introduces the first perioperative anti-PD-1 treatment regimen for adults with resectable locally advanced head ...

Mitsubishi Research Institute and Astellas have agreed on a memorandum of understanding to provide drug-discovery startups in ...

The research program will combine Debiopharm’s AbYlink conjugation technology with Alkyon’s modular antibody platform and ...

TekniPlex Healthcare has commenced production activities at its new 200,000-square-foot facility in Madison, Wisconsin.

How the effectiveness, flexibility and sustainability of single-use technologies solve many of today’s challenges in ...

Over the past decade, the emergence of advanced therapy medicinal products (ATMPs) has fundamentally changed the approach to ...

BioNTech has agreed to acquire CureVac, a clinical-stage biotech company developing a novel class of transformative medicines.

Industry experts weigh in on current trends, challenges, and the future of the cell and gene therapy CDMO market. Cell and gene therapies, which fall under the general classification of advanced ...